Edward White
Stock Analyst at HC Wainwright & Co.
(1.94)
# 3,178
Out of 5,134 analysts
338
Total ratings
32.62%
Success rate
-6.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $12.17 | +171.09% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $10.77 | +57.84% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.49 | +234.08% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.88 | +54.64% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.06 | +1,409.43% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.69 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $9.13 | +776.23% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $3.21 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $4.11 | +386.62% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.00 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.03 | +428.05% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.25 | +376.19% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.85 | +841.95% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $15.07 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.04 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.06 | +89.26% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $20.34 | +150.74% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.75 | +3.70% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $9.40 | +495.74% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.30 | +404.85% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.65 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $30.76 | -2.47% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.34 | +795.52% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $12.17
Upside: +171.09%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $10.77
Upside: +57.84%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.49
Upside: +234.08%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.88
Upside: +54.64%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.06
Upside: +1,409.43%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.69
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.13
Upside: +776.23%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.21
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $4.11
Upside: +386.62%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.00
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.03
Upside: +428.05%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.25
Upside: +376.19%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.85
Upside: +841.95%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $15.07
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.04
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $29.06
Upside: +89.26%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $20.34
Upside: +150.74%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.75
Upside: +3.70%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $9.40
Upside: +495.74%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.30
Upside: +404.85%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.65
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $30.76
Upside: -2.47%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.34
Upside: +795.52%